Chelation and Gadolinium: How Effective is it?
Received Date: Jan 10, 2019 / Accepted Date: Jan 25, 2019 / Published Date: Feb 01, 2019
Abstract
Gadolinium-Based Contrast Agents (GBCA) are intravenous drugs used in diagnostic imaging procedures to enhance the quality of magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA). Recent FDA alerts concerning potential side effects increased patient and medical concerns. We checked if gadolinium remains in the body system longer than pharmaceutical information states and since a growing number of chelation therapists uses chelating agents to remove gadolinium that may have been stored in the body, we checked how effective chelation agents are. Our studies indicate that in the case of gadolinium, chelation does not seem to be an option.
Keywords: Gadolinium; Gadolinium-based contrast agents; GBCA; Chelation; DMPS; DTPA; EDTA
Citation: Blaurock-Busch E (2019) Chelation and Gadolinium: How Effective is it? Diagn Pathol Open 4: 151. Doi: 10.4172/2476-2024.1000151
Copyright: © 2019 Blaurock-Busch E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 9033
- [From(publication date): 0-2019 - Jan 31, 2025]
- Breakdown by view type
- HTML page views: 8175
- PDF downloads: 858
